II. Indications: FDA Approved
- Adults
- Children
- Patent Ductus Arteriosus in the newborn
III. Indications: Off-Label (Not FDA approved)
- Adults
- Pericarditis
- Bartter's Syndrome
- Cluster Headache
- Preterm Labor (Tocolysis)
- Polyhydramnios
- Primary Dysmenorrhea
- Children
IV. Contraindications
- Peptic Ulcer Disease
- Aspirin Sensitivity
- Renal Disease
- Coagulopathy
- Pregnancy beyond 30 weeks
- Childhood (except Patent Ductus Arteriosus)
- Dementia
V. Mechanism
- NSAID in the acetic acid class (indole)
VI. Pharmacokinetics
- Half life: 2 hours
VII. Medications
- Immediate Release Capsules: 25 mg, 50 mg
- Sustained Release Capsules: 75 mg
- Do not open or crush sustained release capsules
- Oral suspension: 25 mg/5 ml
- Suppository: 50 mg
- Only NSAID available in suppository form
VIII. Dosing: Adults
- Precautions
- Limit to lowest effective dose and for least time needed
- See other references for dosing and indications for use in polyhydramnios
- Immediate Release
- Typical dosing range (acute musculoskeletal pain, Dysmenorrhea)
- Start 25 mg orally three times daily with food or milk
- May advance to 50 mg orally three times daily if needed
- Arthritis (RA, OA)
- Start: 25 mg orally twice to three times daily
- May advance to 150 to 200 mg/day divided three to four times daily)
- Acute Gouty Arthritis
- Start 50 mg orally three times daily for 2 to 3 days (until pain is controlled)
- Next 25 mg orally three times daily for 7 to 10 days
- Typical dosing range (acute musculoskeletal pain, Dysmenorrhea)
- Sustained Release (Cluster Headache, acute Gouty Arthritis)
- Dose 75 mg orally daily to twice daily
- Maximum: 200 mg/day (divided three to four times daily)
IX. Dosing: Children
-
Juvenile Rheumatoid Arthritis (not FDA approved)
- Start 1 to 3 mg/kg/day divided 3 to 4 times daily
- May advance as needed to 4 mg/kg/day (up to max: 200 mg/day)
X. Dosing: Preterm Labor
- Precautions
- Associated with risk of significant maternal and fetal complications when used in Preterm Labor (see below)
- Confirm with other references and consult maternal fetal medicine before using Indomethacin in pregnancy
- Protocol 1
- Loading dose: 100 mg suppository rectally
- Maintenance: 25 mg PO every 6 hours for 24 hours
- Repeat for an additional 24 hours maximum
- Protocol 2
- Loading dose: 50 mg PO
- Maintenance: 25 mg PO every 4 hours for 24 hours
- Repeat for an additional 24 hours maximum
- Monitoring
- Amniotic Fluid Index biweekly for use >48 hours
XI. Adverse Effects: General (more than other NSAIDs)
- See NSAID
- See NSAID Gastrointestinal Adverse Effects
- See NSAID Renal Adverse Effects
- Headache
- Peptic Ulcer
- Gastrointestinal upset
- Fluid retention
- Prolonged Bleeding Time
- Nausea or Vomiting
- Pruritus
- Bowel changes
- Mood disturbance
- May worsen Major Depression
- Nephrotoxic
XII. Adverse Effects: Maternal and Fetal
- See NSAID
- Maternal effects
- Fetal effects
- Early ductus arteriosus closure
- Fetal Pulmonary Hypertension
- Oligohydramnios
- Not linked to Intraventricular Hemorrhage
XIII. Safety
XIV. Drug Interactions
XV. Efficacy
- Most potent NSAID (however this carries renal and GI risks)
XVI. Resources
- Indomethacin (DailyMed)
- Indomethacin (StatPearls)
XVII. References
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
Images: Related links to external sites (from Bing)
Related Studies
indomethacin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
INDOMETHACIN 25 MG CAPSULE | Generic | $0.10 each |
INDOMETHACIN 50 MG CAPSULE | Generic | $0.09 each |
INDOMETHACIN ER 75 MG CAPSULE | Generic | $0.26 each |